Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02660554 · ClinicalTrials.gov registry record · NA
Trial of MRSA Polymerase Chain Reaction for Pneumonia
A NA study, sponsored by Northwestern University.
- Completed
- Registry status
- NA
- Development phase
- 45
- Enrollment target
NCT02660554 is a NA study that has completed, run by Northwestern University. The registered enrollment target is 45 participants.
The verdict
NCT02660554, a NA study, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
Study Summary
The purpose of this study is to conduct a randomized clinical trial to compare an antibiotic strategy based on a novel diagnostic test, polymerase chain reaction (PCR) to usual care, in critically ill adults with pneumonia suspected to be caused by methicillin resistant staphylococcus aureus (MRSA). The investigators hypothesize that when automated PCR is used to guide antibiotic therapy, antibiotic exposure will be reduced in critically ill subjects with pneumonia.
Interventions
- OTHER Polymerase Chain Reaction (PCR)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2016-01 |
| Est. Completion | 2019-05-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02660554
The ClinicalTrials.gov registry entry for NCT02660554 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Polymerase Chain Reaction (PCR) is the first listed.
NCT02660554 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02660554 about?
NCT02660554 is a clinical study titled "Trial of MRSA Polymerase Chain Reaction for Pneumonia". The purpose of this study is to conduct a randomized clinical trial to compare an antibiotic strategy based on a novel diagnostic test, polymerase chain reaction (PCR) to usual care, in critically ill adults with pneumonia suspected to be caused by methicillin resistant staphylococcus aureus (MRSA)....
What is the current status of trial NCT02660554?
This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2016-01. Estimated completion is 2019-05-03.
What interventions are being tested in trial NCT02660554?
The interventions under investigation include: Polymerase Chain Reaction (PCR) (OTHER).
Who is sponsoring clinical trial NCT02660554?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.